Jack Ng Kok Wah | Public Health | Best Health Science Research Award

Published on by Scientific World Research Awards

Dr. Jack Ng Kok Wah | Public Health | Best Health Science Research Award

Senior Lecturer | Multimedia University | Malaysia

 

Dr. Jack Ng Kok Wah’s research lies at the intersection of artificial intelligence (AI), surgical innovation, and biomedical engineering, with a strong emphasis on developing AI-driven robotic systems that enhance precision, reduce surgical risks, and revolutionize patient outcomes. His body of work demonstrates a deep commitment to integrating machine learning algorithms and intelligent automation into modern surgical practices, thereby addressing one of the most critical needs in healthcare—precision and safety in complex procedures.A significant aspect of his research explores how robotic technologies and AI-assisted decision systems can transform traditional surgical approaches. By leveraging real-time data analytics, sensor fusion, and computer vision, Dr. Wah contributes to the design of systems that support surgeons in performing minimally invasive procedures with unprecedented accuracy. His work not only advances the technical frontiers of robotic surgery but also examines the broader ethical, clinical, and operational implications of implementing such technologies in real-world healthcare environments.Beyond surgical robotics, Dr. Wah’s research interests extend to digital health innovation, medical imaging, and intelligent clinical systems. He investigates how data-driven approaches can improve diagnostic accuracy, predict patient outcomes, and personalize treatment protocols. Through his publications, he emphasizes the transformative potential of AI to bridge gaps between human expertise and machine efficiency, promoting a synergistic model of healthcare delivery that enhances both safety and accessibility.With a growing citation record and interdisciplinary collaborations, Dr. Wah continues to contribute to the advancement of next-generation medical technologies that merge computing power with human insight. His vision encapsulates a future where AI and robotics are not merely tools but trusted partners in surgical and clinical decision-making, ultimately redefining standards of care in the medical field. His scholarly contributions reinforce his standing as a forward-thinking researcher committed to shaping the future of intelligent healthcare systems and precision surgery.

Profiles: Scopus | ORCID | Google Scholar | ResearchGate 

Featured Publications

  1. Wah, J. N. K. (2025). Revolutionizing surgery: AI and robotics for precision, risk reduction, and innovation. Journal of Robotic Surgery, 19(Article No. 47).
    Citations: 39

  2. Wah, J. N. K. (2025). Revolutionizing e-Health: The transformative role of AI-powered hybrid chatbots in healthcare solutions. Frontiers in Public Health, 13.
    Citations: 29

  3. Wah, J. N. K. (2025). The rise of robotics and AI-assisted surgery in modern healthcare. Journal of Robotic Surgery, 19(1), 311.
    Citations: 13

  4. Ng, J., Wah, K., Fitriana, M., & Arumugam, T. (2023). Assumptions for structural equation modeling (SEM), normality of data distribution analysis & model fit measures. In Normality of Data Distribution Analysis & Model Fit Measures.
    Citations: 12

  5. Wah, K., & Ng, J. (2025). AI-driven robotic surgery in oncology: Advancing precision, personalization, and patient outcomes. Journal of Robotic Surgery, 19(1), 1–11.
    Citations: 7

Dr. Jack Ng Kok Wah envisions a future where artificial intelligence and robotic systems seamlessly integrate into healthcare, enabling safer, smarter, and more precise surgical interventions. His pioneering research drives innovations that enhance patient outcomes, optimize clinical workflows, and redefine the frontiers of intelligent medicine.

Dimitrios Tsiachris | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.

Hengrui Liu | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Hengrui Liu | Medicine | Best Researcher Award

Researcher | University of Cambridge | United Kingdom

Dr. Hengrui Liu is a distinguished researcher at the University of Cambridge, United Kingdom, whose interdisciplinary work spans molecular biology, oncology, pharmacogenomics, and bioinformatics. With a remarkable Scopus h-index of 31, over 2,300 citations, and 55 publications, Dr. Liu has made substantial contributions to understanding cancer biology and translational medicine. His research integrates computational modeling, systems biology, and experimental oncology, focusing on identifying molecular mechanisms underlying drug resistance, tumor progression, and therapeutic targeting.One of Dr. Liu’s notable contributions includes the use of CRISPR screening and cell line IC50 data to uncover genes responsible for trametinib resistance, highlighting potential pathways for targeted cancer therapy. He also explores the role of transcription factors in protein autoubiquitination across multiple cancer types through pan-cancer in-silico profiling, advancing precision oncology approaches. His expertise extends to traditional medicine and integrative therapies, as seen in his recent studies on the role of traditional Chinese medicine (TCM) in improving liver transplantation outcomes, bridging conventional and modern biomedical practices.Dr. Liu’s recent review on the multidimensional role of laminin γ2 (LAMC2) in cancer progression provides a comprehensive understanding of how extracellular matrix components influence tumor behavior and metastasis. His interdisciplinary research brings together molecular mechanisms, clinical relevance, and computational insight, reflecting a holistic approach to biomedical innovation. Moreover, his collaborative network of over 100 co-authors underscores his global impact and leadership in international scientific research.Through his pioneering studies, Dr. Hengrui Liu contributes to the development of novel therapeutic strategies, drug resistance biomarkers, and predictive computational frameworks that enhance the diagnosis, treatment, and prognosis of complex diseases such as cancer. His work exemplifies the synergy between data-driven research and molecular experimentation, reinforcing his reputation as a forward-thinking scientist shaping the future of personalized medicine and biomedical innovation.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Liu, H., et al. (2025). CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance. Open-access Letter. 26 citations.

Liu, H., et al. (2025). In vitro antibacterial activity of neochebulinic acid from aqueous extract of Terminalia chebula Retz against Helicobacter pylori. BMC Complementary Medicine and Therapies. 1 citation.

Liu, H., et al. (2025). An in-silico pan-cancer bulk and single-cell profiling of transcription factors in protein autoubiquitination. Discover Oncology. 2 citations.

Liu, H., et al. (2025). The multidimensional role of laminin γ2 (LAMC2) on cancer progression. Review Article. 0 citations.

Liu, H., et al. (2025). Role of traditional Chinese medicine in supporting liver transplantation outcomes. World Journal of Transplantation. 4 citations.

Shinichiro Sawa | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Dr. Shinichiro Sawa | Medicine | Best Researcher Award

Professor | Kyushu University | Japan 

Dr. Shinichiro Sawa is a highly accomplished Japanese immunologist and medical researcher renowned for his pioneering work in immune regulation, autoimmunity, and inflammation. He currently serves as a Professor at the Institute of Bioregulation, Kyushu University, Japan, where he leads innovative studies in molecular and cellular immunology. Dr. Sawa began his academic journey at Osaka University, earning his Medical Degree (M.D.) in 2000 and subsequently his Ph.D. in Medicine in 2006 from the same institution, where he developed a strong foundation in biomedical sciences and experimental medicine. His professional trajectory includes significant academic roles as Assistant Professor at the University of Tokyo (2011–2016) and Associate Professor at Hokkaido University’s Institute for Genetic Medicine (2016–2018) before joining Kyushu University in 2019. Dr. Sawa’s research interests center on understanding how immune cells, such as γδ T cells, fibroblasts, and plasma cells, interact with tissue environments to regulate immune tolerance, autoimmunity, and inflammatory diseases. His studies, published in prestigious journals such as Nature Immunology, Journal of Clinical Investigation, and Journal of Investigative Dermatology, have shed light on how fibroblasts contribute to central immune tolerance and how plasma cells promote osteoclastogenesis in autoimmune arthritis. His research skills encompass cellular immunology, molecular signaling analysis, animal modeling of immune diseases, flow cytometry, and translational immunopathology, demonstrating both depth and precision in experimental design and interpretation. Recognized for his scientific contributions, Dr. Sawa has received numerous academic honors and research recognitions throughout his career, reflecting his influence in the global immunology community. In conclusion, Dr. Shinichiro Sawa stands as a leading figure in immunological research, bridging basic science and clinical application to advance our understanding of immune homeostasis and to pave the way for novel therapeutic strategies against autoimmune and inflammatory disorders.

Profiles: Scopus | ORCID

Featured Publications

  1. Nonaka, D., Yoshida, S., Nakano, K., Li, X., Okamura, T., Umemoto, E., Yamada, T., Watanabe, M., Jinno, S., Ito, M., Tsuda, M., Noguchi, N., Jiang, X.-J., Sumiya, E., & Sawa, S. (2025). Fibroblast-derived CSF1 maintains colonization of gut mucosal macrophage to resist bacterial infection. Mucosal Immunology.

  2. Onji, M., Sigl, V., Lendl, T., Novatchkova, M., Ullate-Agote, A., Andersson-Rolf, A., Kozieradzki, I., Koglgruber, R., Pai, T.-P., Lichtscheidl, D., Nayak, K., Zilbauer, M., Carranza García, N.-A., Sievers, L., Falk-Paulsen, M., Cronin, S. J. F., Hagelkruys, A., Sawa, S., Osborne, L. C., Rosenstiel, P., Pasparakis, M., Ruland, J., Takayanagi, H., Clevers, H., Koo, B.-H., & Penninger, J. M. (2025). RANK drives structured intestinal epithelial expansion during pregnancy. Nature, 637(8044), 156–166.

  3. Nitta, T., Tsutsumi, M., Nitta, S., Muro, R., Suzuki, E. C., Nakano, K., Tomofuji, Y., Sawa, S., Okamura, T., Penninger, J. M., & Takayanagi, H. (2020). Fibroblasts as a source of self-antigens for central immune tolerance. Nature Immunology, 21(10), 1172–1180.

  4. Nagashima, K., Sawa, S., Nitta, T., Tsutsumi, M., Okamura, T., Penninger, J. M., Nakashima, T., & Takayanagi, H. (2017). Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nature Immunology, 18(6), 675–682.

  5. Onder, L., Mörbe, U., Pikor, N., Novkovic, M., Cheng, H.-W., Hehlgans, T., Pfeffer, K., Becher, B., Waisman, A., Rülicke, T., Gommerman, J., Müller, C., Sawa, S., Scandella, E., & Ludewig, B. (2017). Lymphatic endothelial cells control initiation of lymph node organogenesis. Immunity, 47(1), 80–92.

 

Viktor Savov | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Dr. Viktor Savov | Medicine | Best Researcher Award

PhD Student at Medical University of Varna | Bulgaria

Dr. Viktor Svilenov Savov is an emerging professional in the field of dental medicine, having earned his Master’s degree from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna. His academic journey reflects a balance between clinical training, research engagement, and student leadership, showcasing a multidimensional approach to healthcare development. As President of the Association of Dental Medicine Students – Varna and Vice-President of the Student Council, he demonstrated exceptional organizational and leadership skills, creating opportunities for collaboration, student advancement, and academic visibility. Viktor has actively participated in initiatives that strengthen the link between research, education, and community service, positioning himself as a catalyst for innovation in dental science. Proficient in English and German, with strong communication and computer skills, he is well-prepared to engage in international collaborations. With his dedication to advancing oral healthcare and commitment to academic excellence, he represents a promising future leader in dental research and practice.

Professional Profile

ORCID Profile 

Education

Dr. Viktor Svilenov Savov completed his higher education at the esteemed Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, where he pursued the rigorous program in Dental Medicine and earned his Master’s degree. His educational journey reflects diligence, intellectual curiosity, and a strong desire to excel in both academic and clinical fields. Earlier, he graduated from the First Language High School in Varna, where he developed proficiency in English and German, strengthening his ability to participate in international collaborations. Throughout his studies, Viktor consistently demonstrated a commitment to excellence, engaging with academic societies and contributing to projects that combined theoretical knowledge with practical applications in dentistry. His education provided him with a comprehensive understanding of oral healthcare, clinical procedures, and modern approaches in patient management. This strong academic foundation has prepared him to expand his expertise further through research, collaboration, and leadership in the evolving global landscape of dental medicine.

Experience

Dr. Viktor Savov’s professional and leadership experiences highlight his commitment to advancing both patient care and student development. He worked at MDC “Dentaprime” JSC, where he gained firsthand exposure to dental practices, clinical environments, and organizational workflows. This early experience not only built his clinical adaptability but also deepened his understanding of teamwork in healthcare settings. Beyond professional practice, Viktor has held several leadership positions, such as President of the Association of Dental Medicine Students – Varna, Secretary General of the same association, and Vice-President for the Faculty of Dental Medicine within the Student Council. These roles allowed him to develop strong organizational skills, coordinate large-scale academic events, and advocate for student involvement in research and healthcare initiatives. His ability to balance professional duties with academic leadership demonstrates his dedication to holistic development. Viktor’s experience reflects both a patient-centered approach and an inspiring leadership style that nurtures collaboration and innovation.

Research Interest

Although still at an early stage of his academic career, Dr. Viktor Savov has shown a growing interest in research areas that bridge clinical dentistry, oral health, and patient-centered medical care. His focus lies in exploring innovative approaches to preventive dentistry, oral pathology, and the integration of digital tools into clinical practice. He is particularly enthusiastic about contributing to studies that enhance patient outcomes, improve diagnostic techniques, and develop sustainable solutions in dental medicine. Viktor’s research curiosity is complemented by his active participation in academic societies and student-led initiatives, where he has engaged in discussions around contemporary challenges in healthcare. His multilingual abilities, proficiency in digital tools, and dedication to continuous learning further support his potential for international collaboration. With a strong educational foundation and practical experience, he aspires to contribute meaningfully to research that not only advances dental science but also improves overall community healthcare and global medical practices.

Award and Honor

Dr. Viktor Savov has been recognized primarily through his leadership roles and the honors associated with his academic and organizational contributions. Serving as President of the Association of Dental Medicine Students – Varna stands as a testament to his leadership excellence, where he guided initiatives that fostered collaboration, professional growth, and academic enrichment for his peers. His term as Vice-President in the Student Council and his role as Secretary General further highlight his recognition within the university community as a dependable leader and advocate for student advancement. These positions brought him both respect and acknowledgment for his commitment to service and education. While still building his formal research accolades, Viktor’s leadership honors serve as early indicators of his future potential in academic and scientific recognition. His dedication to service, mentorship, and community engagement has laid the groundwork for future awards and distinctions in dental medicine and healthcare research.

Publication Top Notes

Title: Influence of SLM-, SLS-, and DMLS-Manufactured Titanium Meshes on Bone Gain Parameters and Complications: A Systematic Review
Authors: Viktor Savov; Stefan Peev; Ralitsa Yotsova; Varvara-Velika Rogova
Year: 2025

Conclusion

Dr. Viktor Svilenov Savov embodies the qualities of a dedicated healthcare professional, emerging researcher, and inspiring leader in dental medicine. With a strong academic foundation, professional experience, and proven leadership roles, he has positioned himself as a promising contributor to dentistry and medical research. His interests in advancing oral healthcare, fostering innovation, and strengthening international collaboration reflect his vision for a globally connected scientific community. The honors he has received for his leadership underscore his ability to guide and motivate peers, while his clinical exposure ensures that his approach remains patient-centered. Viktor’s journey demonstrates resilience, intellectual curiosity, and a clear commitment to both science and service. As he expands his research contributions and strengthens international engagement, he is poised to achieve greater recognition in academia and healthcare. With his holistic outlook, dedication, and potential for impactful innovation, Dr. Savov stands as a future leader in dental medicine.